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Introduction 
 
  
Lichen planus (LP) is a chronic mucocutaneous disease affecting skin and mucous 
membrane.  It causes bilateral white striations, papules or plaques on the buccal mucosa, 
tongue, and gingiva. It results due to a cell mediated immunological response to an 
antigenic change in the skin or mucosa35. 
Lesions that appear clinically identical to LP, but caused by drugs are called 
Lichenoid drug eruption (LDE). LDE involving the oral mucous membrane is also 
termed as Lichenoid mucositis (LM). It occurs after the administration of systemic drugs 
such as NSAID, Sulphonyl ureas, Antimalarials, Betablockers, ACE inhibitors, Diuretics, 
Gold salts and Heavy metals15. Clinical and histopathological features of LM & LP are 
similar in many respects.  
 In oral LP, it has been hypothesized that the initiation of the disease process is 
triggered by the permeation of unknown antigens from the oral cavity into the oral 
epithelium17. The passage of antigens through the epithelium is by the entrapment of 
these antigens by Langerhans cells (LC). LC are immunocompetent dendritic cells that 
form a network within the epithelium. They process antigens for presentation to CD4 
helper/inducer T lymphocytes, which in turn will activate CD8 suppressor/cytotoxic T 
lymphocytes. These CD8 cells are responsible for the basal cell degeneration seen in 
LP41. 
In LM associated with systemic drug administration, the mode of access of the 
antigen to the immune system is unlikely to be directly across the epithelium41. It 
probably involves a more remote site of antigen processing and presentation in the 
epithelium without the involvement of LC. This explains the less LC counts in LM as 
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compared to LP and this is due to different modes of antigen processing and 
presentation41. 
Human CD45 is expressed on all cells of hematopoietic origin, except 
erythrocytes. CD45 is a transmembrane tyrosine phosphatase which can exist in at least 
nine different isoforms resulting from tissue-specific alternative RNA splicing of exons 
4-7 of a single gene coding for the various N-terminal peptide segments1. Isoforms of 
CD45 proteins that are expressed on a restricted group of cell types are designated as 
CD45R. Most naive human T cells, recognized as CD45RA, express a form of CD45R 
and contain a segment encoded by an exon designated A. Memory T cells express a 
different isoform called CD45RO that contains none of the alternatively spliced exons. 
They are present on most thymocytes, a subpopulation of resting (memory) T cells within 
both CD4 and CD8 subsets as well as on monocytes and granulocytes1. 
When naive cell encounter antigen, they differentiate into effector lymphocytes 
that have functions in protective immune responses. Naive-T-cells produce IL-2 which 
functions as growth & differentiation factor for T-cells1. Effector T cells includes 
cytokine secreting CD4+ helper T cells and CD8+ cytotoxic T cells. Some of the progeny 
of antigen activated T cells differentiate into memory cells that survive for long periods 
in a quiescent state. These memory cells are responsible for the rapid and enhanced 
responses to subsequent exposures to antigen1. 
With this background, we did this study to compare the clinical and 
histopathological features of LP & LM and to evaluate the number & activity of LC and 
T cells, by using monoclonal antibody CD1a & CD45RO, to determine the possible 
different immunopathogenic mechanisms of these lesions. 
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      Aims & Objectives  
 
  
 
 
HYPOTHESIS 
         There is an increase in expression of T cells and Langerhans cells in Lichen planus 
when compared to Lichenoid mucositis 
 
 
 
AIMS AND OBJECTIVES 
1. To identify & evaluate LC in LP, LM and normal mucosa using CD1a 
monoclonal antibody immunohistochemically. 
2.  To identify & evaluate memory T cells in LP, LM and normal mucosa using 
CD45RO monoclonal antibody immunohistochemically. 
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Review of Literature 
 
  
LANGERHANS CELL 
 
In 1868 Paul described a dendritically shaped cell population located in squamous 
epithelia of the epidermis, in the suprabasal layers, by using a gold chloride impregnation 
technique. For many years Langerhans cells (LC) were regarded as ectodermal cells, 
artifacts, melanocytes or neural elements such as schwann cells. These cells represent 
about 4% of epidermal cells in man39. 
For almost 100 years, these cells remained unattended. With the aid of electron 
microscope Birbeck et al demonstrated in these cells the presence of rod shaped 
intracytoplasmic granules with transverse periodic striations that are considered today as 
LC. These granules are probably derived from the plasma membrane and they seem to be 
involved in receptor mediated endocytosis39. 
LC are members of a family of highly specialized antigen presenting cells (APC) 
termed as Dentritic cells. The term Dentritic has been used to denote members of this 
family of cells having the same characteristic morphology and immunologic features. 
This series of cells include LC possessing Birbecks granules, interdigitating cells within 
T cells area of lymphoid tissues and so called Vieled cells found in afferent lymph 
vessels27. 
LC are localized at the interface between the organism and the environment and 
are important sentinels of the immune system. In aggregates, LC form a continuous 
network of cells that are equipped to ingest intruding microbes and other environmental 
components and process the complex antigen into small fragments that can be recognized 
by T cells27. The unique migratory ability of LC allow them to transport antigen from 
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epidermis to regional lymph nodes, where they can initiate a systemic immune response 
by presenting cell surface bound processed antigen to resting T lymphocytes27. 
ORIGIN 
 Since 1868, because of their staining behavior, their dendritic morphology and an 
apparent continuity with their nerve fibers of the dermis, LC were first thought to represent 
intraepidermal nerve cells51. 
In late 1940 it was known as LC were aged or worn out melanocytes that had lost 
their ability to produce pigments, left their basal localization and were in the process of 
being exfoliated18. 
In 1961, detailed description of the ultra morphology LC with demonstration of 
Birbeck granule has become the hallmark of LC39.  
 In 1979, Katz and Frelinger27 et al introduced the concept that LC are derived 
from a mobile pool of bone marrow precursors. Although LC are clearly myeloid cells, 
immediate precursors of LC have not been identified. There may be a small population of 
LC that can proliferate insitu, but it is generally agreed that the bulk of LC are 
postmitotic27. Thus LC must derive from blood borne committed precursor or from less 
differentiated precursors that assumes the characteristic of LC locally27. In 1996, Winning 
et al suggested that LC are derived from monocyte lineage of bone marrow cells68. 
LC was thought to be of mesenchymal origin after Birbeck granules were 
identified in Histiocytosis X cells and this introduced the concept of LC as immune cell. 
Close apposition of lymphocytes and LC in the epidermis, accumulation of LC in 
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lymphatics, increased LC in dermis after antigen challenge led to the concept that LC 
might transport antigen acquired in the epidermis to regional lymph nodes27. 
The demonstration of Fc and complement receptors, as well as MHC on the 
surface of LC finally consolidated their role as a cell of immune system. LC are members 
of a family of highly specialized antigen presenting cells (APC) termed as dendritic cell 
system27. 
Even in the absence of obvious stimulation there seems to be a slow, but 
continuous turn over of LC.  Local activation of LC by contact allergen or irritants lead to 
a dramatic increase in the number of LC that leave the epidermis and migrate to regional 
lymph nodes via the afferent lymphatics. During this phase of their life history, LC 
undergo dramatic functional and phenotypic changes that enable them to act as potent 
APC activating unprimed T cells in the paracortical areas of regional lymph nodes27. 
Not until the late 1980 it was conclusively demonstrated that LC could take up 
antigen in epidermis, migrate to regional lymph nodes and present imported antigen to 
naive T lymphocytes in a MHC restricted manner. Freshly obtained LC and LC insitu are 
effective in taking up and processing protein, microbial and particulate antigen but 
present antigen inefficiently. Only after activation (eg by contact allergens, microbial 
products or proinflammatory cytokines) do LC leave the epidermal compartment and 
migrate via afferent lymphatics to regional lymph nodes27. 
During this process, LC upregulates surface expression of MHC and co 
stimulatory molecules and thus acquire the functional characteristics of professional 
APCs when they reach the T cell area of the draining lymph node. This transition in LC 
phenotype and functional activity is called LC maturation27. 
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FUNCTION 
 LC are specialized cells with immune functions resembling those of other 
dendrite cells and of macrophages. In fact, LC have been shown to be able to migrate and 
to handle antigen in a manner similar to that of the antigen presenting cells such as 
macrophages, B cells and other dendritic cells. LC expresses MHC class II antigens at 
their surface, and through these molecules it can present the antigen to T cells39 . 
 It is now well established that T lymphocytes do not recognize the antigen by 
itself. This needs first to be taken up by APC, degraded (processed) by proteolytic 
digestion, and re-expressed (presented) at their surface in the context of the MHC 
molecules. T cells then recognize the antigen under the form of an epitope associated 
with class I & class II molecules39. The recognition of an epitope in the context of MHC 
class II molecules (DR, DP, DQ of the HLA in humans) is essentially done by T helper 
(CD4) cells, whereas T cytotoxic (CD8) cells mainly recognize the epitope when it is 
associated with class I molecules (HLA-A, HLA-B, HLA-C). This is commonly defined 
as MHC restriction of T cell activation39. 
  Other non-specific factors like LFA-1, ICAM-1, LFA-3 as well as certain 
cytokines such as IL-1, IL-6 can act on T cell activation depending on the activation and 
maturation of the T cell39. 
  It is now established that epidermal cells can induce antigen driven proliferation 
of sensitized T cells and that this property is essentially linked to the presence of class II 
bearing LC. Using ‘ purified’ epidermal LC, several authors have shown that LC can 
present antigen to both helper and cytotoxic T cells specific for protein antigens, haptens 
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and alloantigens and that the removal of LC from the epidermal cell population 
eliminates this stimulatory effect39. 
 It is reasonable to postulate that resident LC take up the antigens, thus specifically 
stimulating resting T helper and cytotoxic cells either locally or, after migration, in the 
draining lymph nodes. Furthermore, the similarity existing between resident LC and 
certain macrophage/monocyte like cell suggests that LC could possess clearance and 
effector functions, as well as the property of secreting active mediators IL-1. All this 
would suggest a key role for LC in the induction of protective immune responses against 
a wide variety of antigenic stimuli and also of producing immunopathological reactions 
taking place at cutaneous and /or mucosal level39. 
 Considering the fact that skin and mucosae are continuously exposed to a variety 
of injurious agents, often having antigenic features, LC may well represent a ‘first line’ of 
sensitization of the immune system, leading to clearance of the antigen or to a 
pathological phenomena. It is reasonable to see LC as participating in the pathogenesis of 
some cutaneous and mucosal pathological entities39. 
IDENTIFICATION: 
Classical histology:  
LC appears as high-level clear cell in light microscopy sections stained with H & 
E. Certain particular methods also can detect this cell. Technique employed were metal 
impregnation staining such as gold, osmium iodide or zinc osmium iodide39. 
Histochemistry:  
The demonstration of a membrane bound, formalin resistant, and sulfhydryl 
dependant adenosine triphosphatase (ATP-ase) is an excellent method for identification 
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of human LC. These cells are predominantly found at a suprabasal level and rarely in the 
basal layer. Although the dendrites may give the impression of forming an interconnected 
network, unequivocal contact between LC remains to be demonstrated39. 
Electron microscopy:  
 The Birbeck granules seem to be specific marker of LC. They possess tennis 
racket morphology with transverse striations. Their function was presumed to be 
receptor-mediated endocytosis. It has been recently suggested that at least a part of the 
cytoplasmic Birbeck granules are not isolated cytoplasmic organelles but they result from 
a fragmentation of the tubular structure called ‘the continuous endosomal reticulum’ 39. 
Two types of LC have been described: 
Type I – Highly dendritic with an electronlucent cytoplasm, numerous granules 
and is usually found in the suprabasal layer. 
Type II - Shows fewer dendrites, a more electron dense cytoplasm, fewer Birbeck 
granules and is located in the basal layer39. 
Six electron microscopic criteria of specificity for LC have been used: 
1. Indented or lobulated nucleus 
2. Birbeck granules 
3. Absence of tonofilaments 
4. Well developed golgi apparatus with a clear cytoplasm 
5. Absence of desmosomes 
6. Absence of melanosomes & premelanosomes. 
LC has a prominent network of microfilaments as well as a system of 
microtubules. Both these features are evidences of a capacity to migrate39. 
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Immunolabeling:  
A large number of surface and/ or cytoplasmic antigens have been localized on 
LC by means of antibodies used in either immunofluorescence or immunoperoxidase 
techniques. Though many or even all of them are important for LC functions, only those 
antigen/antibody reactions that are displayed by all LC but not expressed by other cells 
within the epithelium can be employed for LC identification39. 
One of the most prominent features of LC is the high level of expression of MHC 
class II antigens. In addition to the MHC class II antigens, MHC class I antigens have 
been shown on LC as well as the leukocyte common antigen (CD45). The latter antigen is 
a marker for cells of haemopoietic origin and stresses the bone marrow origin of LC39. 
 Molecules within the group of integrins (adhesion molecules) involved in cell-to-
cell interactions have also been demonstrated on LC. These molecules include the 
lymphocyte function associated antigen LFA-1 (CD11a) and the very late activation 
antigen VLA (CDw29). CD4, originally considered to be restricted to the helper 
lymphocyte subpopulation, has also been identified on LC. This antigen plays an 
important role in the activation of T cells, together with the T cell receptor and MHC 
class II antigens39. 
Among the markers used, anti CD1a (T6) immunolabeling is considered to be the 
most reliable to identify the human LC in the epithelium39. 
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T LYMPHOCYTE 
Cell mediated immunity is mediated by T lymphocytes. T-cells occur either as 
helper T-cells, which assist B-cells in the production of antibody, or as cytotoxic T-cells, 
which stimulate the microbiocidal and cytotoxic activity of other immune cells including 
macrophages. Lymphocyte-mediated recognition of antigen shows specificity, as well as 
memory1. 
T lymphocytes recognize the antigens through antigen receptors, membrane 
molecules distinct from but structurally related to antibodies. Antigens are captured from 
their site of entry by dentritic cells and concentrated in lymph nodes, where they activate 
naïve lymphocytes that migrate to the nodes through blood vessels. Effector and memory 
T cells develop in the nodes and enter the circulation from which they migrate to 
peripheral tissues1. 
             T cells develop diversity for reacting against different specific antigens. The 
activated T-helper cells then produce factors, which stimulate B-cells to undergo 
differentiation into plasma cells and eventually produce antibodies. Activated T-helper 
cells also produce factors, which stimulate cytotoxic cells and phagocytes, arming them 
for microbiocidal or cytotoxic activity1.  
CHARACTERISTICS OF NAÏVE, EFFECTOR & MEMORY LYMPHOCYTES 
  Naive T cells are unprimed lymphocytes that have been stimulated by antigen to 
become immune competent lymphocytes. When they encounter antigen, they 
differentiate into effector lymphocytes that have a function in protective immune 
responses. Naive-T-cells produce IL-2 which functions as growth & differentiation 
factor for T-cells.  Effector T cells includes cytokine- secreting CD4+ helper T cells 
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and CD8+ Cytotoxic T cells. Some of the progeny of antigen activated T cells 
differentiate into memory cells that survive for long periods in a quiescent state. These 
memory cells are responsible for the rapid and enhanced responses to subsequent 
exposures to antigen1. 
ROLE OF CD45 IN T CELL ACTIVATION 
CD45 a cell surface glycoprotein with a cytoplasmic tyrosine phosphatase domain 
is believed to play a role in T cell activation. Various forms of CD45 are expressed on 
immature and mature leukocytes, including T and B cells, thymocytes, mononuclear 
phagocytes and polymorphonuclear leukocytes. The CD45 family consists of multiple 
members that are all products of a single complex gene. This gene contains 34 exons, and 
the primary RNA transcripts of three of the exons (called A, B and C) are alternatively 
spliced to generate up to eight different messenger RNAs and eight different protein 
products1. 
The predicted aminoacid sequences of the protein products include external 
domains of varying lengths, a transmembrane region and a 705-aminoacid cytoplasmic 
domain that is one of the largest identified among membrane proteins. Isoforms of CD45 
proteins that are expressed on a restricted group of cell types are designated as CD45R. 
Most naïve human T cells express a form of CD45R that is called CD45RA, whereas 
memory T cells express a different isoforms called CD45RO1. 
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LICHEN PLANUS 
Lichen planus is a unique, common inflammatory disorder that affects the skin, 
mucous membrane, nails and hair. In Greek ‘Leichen’ means ‘tree moss’ and in Latin 
‘planus’ means ‘flat’. Because Leichens are primitive organisms of symbiotic algae and 
fungi, it can be assumed that the clinical appearance of lesions LP represent reminiscent 
of liechens growing on rocks. The term suggests it as a flat fungal infection but current 
evidence proposes it as a mucocutaneous disorder mediated by numerous complex 
immunologic events21. 
HISTORY21 
• Erasmus Wilson was the first person who described the condition leichen (lichen) 
planus in1869. 
• Kaposi first described a distinctive clinical variant of the disease with blisters, lichen 
rubber pemphigoides, in 1892. 
• Wickham described the characteristic appearance of whitish striae and punctuations 
that develop atop the flat surface papules in 1895. 
• Dubreuill first described the histopathological features of OLP that are characteristic 
and similar to those of cutaneous LP in 1906 
• Darier elaborated the histological findings in1909.  
ETIOLOGY 
LP is multifactorial in origin with an immunopathogenesis involving T cells in 
particular. The etiopathogenesis appear to be complex, with interaction between genetic, 
environmental, and lifestyle factors and new associations such as with liver disease. 
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 i) AUTOIMMUNITY 
Sugerman PB, Savage NW, Walsh LJ et al (1993)60 proposed that in oral lichen 
planus (OLP) diverse exogenous agents such as drugs, trauma & infection stimulate the 
expression of a common self-molecule by oral mucosal keratinocytes. An autoimmune 
reaction by cytotoxic T lymphocytes to these activated keratinocytes may result in the 
tissue destruction, which is characteristic of OLP.  
Bramanti TE, Dekker NP, Nur FL et al (1995)6 studied Heat shock proteins 
(HSP) as the antigen stimulus in autoimmune diseases. They concluded that although the 
expression of HSP was altered in LP, the difference demonstrated was slight and were 
therefore inconclusive.  The HSP contribute to the persistence or chronicity of the 
disease, or they could have simply reflected cellular injury. 
Chaiyarit P, Kafrawy AH, Miles DA et al (1999)10 hypothesized that in a 
genetically predisposed individual; a hapten, a conventional antigen or a super antigen of 
oral microbial origin could induce a cell-mediated immune response with subepithelial 
infiltration of T cells. Generation of cytokine by these cells may upregulate the 
expression of Heat shock proteins HSP 60 in the adjacent basal keratinocytes. If the 
individual is predisposed to react to HSP 60 by virtue of possession of certain HLA 
antigen then a second immune reaction follows with development of cytotoxic T 
lymphocyte that target basal keratinocyte causing autoimmune reaction and destruction of 
basal cells. The author concludes suggesting that HSP 60 plays a role in the pathogenesis 
of OLP. 
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ii) INFECTION 
Sand LP, Jalouli J, Larsson PA et al (2002)53 studied that Epstein Barr virus 
(EBV) is present in oral diseases such as oral squamous cell carcinoma (OSCC) and 
OLP. Of the 23 OLP patients, 26.1% were EBV positive. 
Chainani-Wu N, Lozada-Nur F, Terrault N (2004)8 reviewed an association 
between OLP and HCV infection by a search of the computerized database MEDLINE 
(1966-June 2003). Biases-including selection bias and investigation bias in the studies 
published-make it difficult to draw firm conclusions. 
Campisi G, Giovannelli L, Arico P et al (2004)7 evaluated the prevalence of 
human papillomavirus (HPV) infection in 71 OLP in comparison with that in healthy oral 
mucosa. An increased risk of HPV infection was found in OLP; however, no specific 
clinical variant of OLP was noted to be associated with HPV infection. 
Cunha KS, Manso AC, Cardoso AS et al (2005)14 studied 134 patients with 
HCV infection. The prevalence of OLP was 1.5% in patients with HCV infection and 
1.1% in the control group. There was no statistically significant difference between the 
two groups (p- 0.630) in Brazilian patients. 
iii) STRESS 
McCartan BE (1995)40 studied 50 patients with OLP for current anxiety and 
depression and for related personality factors. There were no statistically significant 
associations between erosive oral LP and either anxiety or depression.  
Garcia-Pola M.J, Huertaa G, Cereros R et al (2001)22 suggested that anxiety 
and depression constitute risk factors that could influence the development of OLP. 
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Koray M, Dugler O, Horasanli S et al (2003)33 studied the evaluation of anxiety 
and salivary cortisol levels in 40 patients with OLP and found that salivary cortisol and 
anxiety levels in OLP group were significantly higher than in the control group. 
  Chaudhary S (2004)12 studied psychosomatic factors and their association in LP. 
Significantly higher stress, anxiety and depression levels were found in the OLP than the 
general population. These suggest that psychological stresses play an important role in 
the causation of OLP. It may be further hypothesized that these stresses form a starting 
point for the initiation of various autoimmune reactions, which have been shown to the 
pathogenesis of OLP. 
iv) CELL MEDIATED IMMUNITY 
Zhao ZZ, Sugerman PB, Zhou XJ et al (2001)72 studied that OLP lesional T 
cells produce & secrete RANTES, which triggers human mast cell degranulation. 
Degranulating mast cells release TNF alpha which upregulates OLP lesional T cell 
RANTES secretion. Such a cyclical mechanism may underlie disease chronicity. 
Zhao ZZ, Savage NW, Sugerman PB et al (2002)73 showed the interaction 
between mast cell & T cells of immune regulation contributing to cell mediated 
inflammatory response of OLP. 
Zhao ZZ, Sugerman PB, Walsh LJ et al (2002)71 hypothesized that RANTES & 
CCR1 may play important roles in mast cell trafficking & related events in OLP. 
Sugerman PB, Savage NW, Walsh LJ et al (2002)59 reviewed both antigen 
specific & non antigen specific mechanisms may be involved in the pathogenesis of OLP. 
Antigen specific mechanism includes antigen presentation by basal keratinocytes and 
antigen specific keratinocytes killing by CD8 cytotoxic cells. Antigen non-specific 
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mechanism includes mast cell degranulation and MMP activation. These mechanisms 
may combine to cause T cell accumulation in the superficial lamina propria, basement 
membrane distribution, intra epithelial T cell migration and keratinocyte apoptosis in 
OLP. 
 Khan A, Farah CS, Savage NW et al (2003)31 reported cell mediated immune 
response in OLP may be regulated by cytokines and their receptors. They suggested that 
the development of a T helper1 immune response might promote CD8 cytotoxic T cell 
activity in OLP. 
Walsh LJ (2003)64 suggested mast cell proteases might contribute to alterations 
in the basement membranes in inflammation in the oral cavity, such as the distributions 
that allow cytotoxic lymphocytes to enter the epithelium in OLP. 
CLINICAL FEATURES 
 Lichen planus often affects the oral mucosa and often may occur without skin 
lesions. About half of the patients with skin lesions have oral lesions, whereas about 25% 
present with oral lesions alone. The prevalence of LP in the general population is 
estimated as 0.9% - 1.2%, whereas the prevalence of OLP has been reported between 
0.1% - 2.2%. OLP is the disease of adulthood occurring at ages ranging from 30 – 70 yrs 
and about 60 – 65% of the patients being females28. 
 OLP may be found in any locations but favored sites are the buccal mucosa, the 
tongue, and the gingiva, whereas palatal lesions are uncommon. The lesions are always 
bilateral28. OLP is classified according to its clinical features as reticular, papular, plaque, 
bullous, atrophic, erosive, and ulcerative. Reticular LP is the most common form and 
predominantly affects buccal mucosa, appearing as a network of white or grey threads 
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(Wickham’s striae) interspersed with papules or rings (Fig 1). Vesicle and bulla 
formation has been reported but this is not a common findings. Atrophic lesions may 
appear with or without erosions. Erosive type is most likely to cause symptoms, which 
include a spectrum ranging from spontaneous soreness to severe pain, exacerbated by 
local irritants. OLP may resemble other mucodermatoses such as lupus erythematosus, 
pemphigoid, leukoplakia, and especially the so-called OLM28. 
HISTOPATHOLOGY 
 In 1906, Dubreuill first described the histopathological features. Typical findings 
include hyperorthokeratinization or hyperparakeratinization with thickening of granular 
cell layer. The epithelium displays local acanthosis, with inter and intra cellular edema. 
The saw tooth appearance of the reteridges is commonly found in skin lesions and rarely 
in OLP28. 
The earliest findings are an increase in the number of epithelial LC. A well-
defined band like inflammatory cell infiltrate, consisting mainly of lymphocytes, 
develops in the subepithelial connective tissue (Fig 3). This is followed by liquefaction 
degeneration of basal cell layer and the appearance of a thin band of eosinophilic material 
immediately underlying the basement membrane28.  
Colloid bodies (also called as cytoid, hyaline or civatte bodies) may be seen lying 
either in lower layer of epithelium or within the upper layer of the connective tissue28. 
The civatte bodies are isolated epithelial cells, shrunken with eosinophilic cytoplasm and 
one or multiple pyknotic nuclear fragments. They represent apoptotic keratinocytes and 
other necrotic epithelial components that are transported to the connective tissue for 
phagocytosis15.  
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LICHENOID MUCOSITIS 
Lichen planus like eruptions were first reported in military personnel in World 
War II who had been prescribed antimalarial drugs. This phenomenon has been termed as 
Lichenoid drug eruptions (LDE). LDE involving the oral mucous membrane was termed as 
Lichenoid mucositis (LM) or Oral Lichenoid lesions (OLL). LDE was recognized as a 
variant of LP till 1929. Many of these cases were biopsied to show appearances identical 
and similar to idiopathic LP. However, the number of drugs confirmed as precipitating 
LDE in oral mucous membranes is small, and only a few patients with LP have a history of 
systemic drug therapy with known lichenoid inducing drugs38. 
Pinkus H (1973)21 defined Lichenoid tissue reaction “as one exhibiting epidermal 
basal cell damage and the chain of histobiologic events resulting from such damage. It is 
not essential whether damage to the basal cells is primary or is itself due to preceding 
events in the dermis. Alterations affect both tissues. This tissue reaction may be called 
‘lichenoid’ because lichen planus is the protype.” 
ETIOLOGY 
Penneys NS, Ackerman B, Gottlieb et al (1974)46 reported Quinacrine and 
Mepacrine, used as antimalarials during World War II, were seen to cause lichenoid 
lesions. Apart from these drugs, gold was probably the most common agent recognized as 
initiating a LM. 
Laeijendecker and Van J (1994)36 studied that gold salts can cause a range of 
mucocutaneous lesions, of which oral lichenoid lesions may be the first. 
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Van Dis and Parks (1995)62 suggested the drugs most commonly implicated in 
lichenoid reactions are the Non-steroidal anti-inflammatory drugs (NSAID) and the 
Angiotensin-converting enzyme (ACE) inhibitors. 
 McCartan BE and McCreary CE (1997)42 studied that LM occurs after the 
administration of systemic drugs such as NSAID, Sulphonyl ureas, Antimalarials, 
Betablockers, ACE inhibitors, Diuretics, Gold salts and Heavy metals. 
Scully and Diz (2001)56 suggested that LM also may follow the use of HIV 
protease inhibitiors, Antihypertensive agents, Antimalarials, Phenothiazines, 
Sulphonamides, Tetracyclines and Thiazide Diuretics. 
Segura-Egea JJ, Bullon-Fernandez P et al (2004)57 reported a case of oral 
lichenoid reaction associated to amalgam restoration.  Biopsy showed histological 
changes compatible with oral lichen planus. Other restorations were performed with 
composite resins, and no reaction was evidenced in the mucosa. 
Issa Y, Brunton PA, Glenny AM et al (2004)25 concluded that the replacement 
of amalgam restoration could result in the resolution or improvement of OLLs. The study 
population consisted of 1158 patients (27% male and 73% female; age range, 23-79 
years). From 16% to 91% of patients had positive patch test results for at least 1 mercury 
compound. Thus topographic relationship between an OLL and an amalgam restoration is 
a useful-but not conclusive marker. 
Issa Y, Duxbury AJ, Macfarlane TV et al (2005)26 investigated a total of 51 
patients, who had oral lesions related to their dental restorations of which twenty seven 
(53%) patients had positive patch test. They concluded that OLL might be elicited by 
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some dental restorations. Replacing restorations adjacent to these lesions is associated 
with healing in the majority of cases particularly when lesions are in close contact with 
restorations.            
CLINICAL FEATURES 
  
 LM occur unilaterally with mean age of 57 yrs. LP occur at a younger age group 
(a decade earlier) than LM. For OLL, the latent period between the beginning of 
administration of a drug and the appearance of the eruptions is about 1 or 2 weeks, or up 
to 1 month23.  
The latent period is dependent on the offending drug but other factors may also 
play a role in determining its duration, that is, the dosage of the drug the patient’s 
individual reaction to the drug, and treatment with other drugs. The latent period may be 
shortened significantly if the patient has been previously exposed to the offending drug23. 
 Lesions of LM can be similar to those of idiopathic LP or have an atypical 
appearance (Fig 2). LM may have eczematous papules and a generalized eczematous skin 
reaction with marked desquamation. Lesions of LM are considered to be more 
psoriasiform and larger than lesions of idiopathic LP23.  
Wickham’s striae are usually, but not always, absent in lesions of LM. A greater 
tendency towards residual hyperpigmentation has been noted in LM. Severe alopecia can 
accompany LM because of follicular involvement. In some patients decreased sweat 
production can also occur, atrophy of the dermal portion of the sweat duct has been 
observed23.  
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HISTOPATHOLOGY 
 
 The histological features distinguishing LM from LP are a subepithelial infiltrate, 
containing eosinophils and plasma cells which is more diffuse and which extend more 
deeply than in LP, perivascular infiltrate, parakeratosis and the presence of colloid bodies 
(Fig 4)42. 
 Despite the reported difference between LP & LM, the WHO criteria for LP do 
not distinguish between the two conditions (WHO collaborating center for oral 
precancerous lesions, 1978) 42. 
There is no specific test for LM. Although resolution and recurrence of LM on 
withdrawal and re-exposure to the drug is probably diagnostic, the eruptions may persist 
for long periods following withdrawal of the drug.  However, a combination of a history 
of current use of a known LDE inducing drug, a histological appearance consistent with 
LM and a detectable presence of circulating basal cell cytoplasmic autoantibody (BCCA) 
may help in the diagnosis of LM when drug substitution or withdrawal is impractical42. 
 Damage to the basal cells is a feature of both LM & LP, and perhaps initial basal 
cell damage by drug therapy is involved in initiating the production of these 
autoantibodies called BCCA. These were significantly associated with systemic drug 
usage, histologic diagnosis of a LM and a unilateral intraoral distribution of the clinical 
lesion38. 
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ROLE OF LANGERHANS CELLS IN LP & LM 
Bhan AK, Harrist TJ, Murphy GF et al (1981)3 studied 4 patient of LP using 
monoclonal antibodies. Intraepidermal and dermal cells with long cytoplasmic extensions 
stained with any anti-T6 antibody in all cases, was termed as LC or their precursors. T6-
positive cells were seen in greater number than in normal control epidermis and dermis. 
The results indicate that well-developed lesions of LP are characterized by an increased 
numbers of LC. These observations support the contention that cellular immunity is 
important in the pathogenesis of this disorder. 
Sloberg K, Jonsson R, Jontell M et al (1984)58 demonstrated an increased 
amount of Ia-like antigens per number of T6-positive LC in LP of oral mucosa compared 
to healthy conditions. This increase in expression of LC in LP is a property of LC to 
improve heir capacity to detect and present antigen to the subepithelial T lymphocytes. 
The increased expression of Ia-like antigens on LC and the contemporary finding of Ia-
like antigens on the subepithelial T-cells support the opinion that the pathogenesis of 
OLP is mainly a cell-mediated type of immunological reaction. 
Regezi JA, Stewart JC, Lloyd RV et al (1985)50 studied 20 patients with 
clinically and microscopically confirmed lichen planus immunohistochemically using S-
100 protein. It was concluded that langerhans cells, macrophages, and keratinocytes play 
important roles in antigen processing and/or phagocytosis during the natural history of 
this disease. Although there was an actual influx of additional LC into the epithelium in 
active state of LP, it could be argued that this may be more apparent than real. Increased 
metabolic activity and antigenic challenge could account greater production HLA-DR 
antigen expression of resident LC without real influx of LC. 
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Arachchi PA, Crane IJ, Scully C et al (1989)2 studied the epithelial dendritic 
cells (EDC) in non-specific keratosis, lichen planus and OSCC. Monoclonal antibodies to 
the human CD1 thymocyte (OKT6) and HLA-DR antigens were used. Significantly more 
T6+ and DR+ EDC were present in lichen planus tissues than normal controls, non-
specific keratosis and OSCC. Significantly fewer T6+ EDC and significantly more DR+ 
cells were present in the invasive epithelium of squamous cell carcinomas than the 
overlying/adjacent epithelium of carcinomas, the non-specific keratosis group and the 
normal tissues. The results suggest that immunological enhancement occurs in lichen 
planus and possibly immunological impairment may characterize invasive OSCC. 
 Bolewska J and Reibel J (1989)4 studied that patients with mucosal lesions 
confined to areas opposing amalgam restorations (contact lesions) show a high rate of 
allergic reaction towards mercury. These lesions may, therefore, represent a contact 
hypersensitivity reaction and have a lichenoid appearance. The authors therefore 
evaluated the presence of lymphocyte subpopulations, LC and the expression of HLA-DR 
antigens on mucosal keratinocytes in biopsies of contact lesions (Group 1) and in OLP 
with (Group 2) and without (Group 3) partial contact with amalgam restorations. T 
lymphocytes dominated in all three groups and LC counts were similar. HLA-DR 
positive keratinocytes were found in 18-36% of lesions in all three groups. Thus, the 
immunologic parameters examined are not of value in discriminating between the types 
of lesions studied.  
Chou MJ and Daniels TE (1989)13 compared LC expressing HLA-DQ, HLA-
DR and T6 antigens in biopsies from 12 patients with OLP and 8 healthy volunteers. LC 
expressing each antigen was observed in all the specimens, but in LP the cells were 
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located in higher levels of the epithelium than in controls. In LP specimens, there were 
significantly more LC expressing HLA-DQ and T6 than HLA-DR (P - 0.0001 and 0.02 
respectively); no such differences were found in normal mucosa.. They concluded that in 
LP there is modulation of HLA-DR and HLA-DQ antigen expression by LC, or 
differences in the number of LC expressing those antigens. 
Farthing PM, Matear P, Cruchley AT (1990)20 studied the numbers of CD1, 
HLADR, HLADP and HLADQ +ve intraepithelial dendritic cells in lesions of OLP and 
normal oral mucosa using a pannel of antibodies. In LP, the cells appeared more dendritic 
and equal numbers of CD1, HLADR, HLADP and HLADQ positive cells were found, 
with significantly more than in normal mucosa. These results show that although there is 
no change in the total number of LC in LP, there is an increase in Class II MHC antigen 
expression. This suggests that in LP, LC are immunologically active and play a role in 
lesion development. 
Farthing PM, Matear P, Cruchley AT (1992)19 showed in LP, an increase both 
in the number of LC and the numbers expressing CD4 were found in areas of 
keratinocyte HLADR expression and compared it with HLADR negative areas and with 
normal oral mucosa. There was no difference in the numbers of LC or their expression of 
CD4 between HLADR-negative areas in LP and normal oral mucosa. These results show 
that the distribution of LC is related to keratinocyte expression of HLADR and suggest 
that LC entry may be enhanced in these areas. While this enhancement is mediated by 
CD4/HLADR interaction, other molecules are also likely to be important in controlling 
LC entry into oral mucosa. 
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  Lombardi T, Hauser C, Jorgensen BE (1993)39 described LC as dendritic bone 
marrow derived cells situated suprabasally in most stratified squamous epithelia, such as 
the epidermis and the epithelium of oral mucosa, including the gingiva. LC is thought to 
act as antigen-presenting cells (APC) during induction of immune responses. The exact 
role of langerhans cells in the oral mucosa is not fully understood although several 
investigations suggest that these cells are involved in reactions to antigen challenge under 
both normal and pathological situations.  
Walton LJ, Thornhill MH, Farthing PM (1994)67 examined the expression of 
intercellular adhesion molecule-1 (ICAM-1, CD54) and vascular cell adhesion molecule-
1 (VCAM-1, CD106) in OLP and normal oral mucosa (NOM). Immunoperoxidase 
staining showed ICAM-1 expression by vascular endothelium in all biopsies of OLP and 
NOM whereas endothelial VCAM-1 staining was found in 2/7 NOM and 8/9 OLP. 
Intraepithelial dendritic cells stained for ICAM-1 in 7/9 and VCAM-1 in 4/9 OLP 
biopsies. Double immunofluorescence showed dual labeling of LC with CD1a and 
VCAM-1 in a further 5/12 cases of OLP, but there was no such staining in four NOM. 
They concluded that induction of ICAM-1 and VCAM-1 on LC and macrophages in OLP 
could cause these cells to be activated and may contribute to the pathogenesis of OLP by 
presenting antigen to infiltrating lymphocytes. 
 Kirby AC, Olsen I, Farthing PM (1995)32 studied the expression pattern of 
lymphocyte function-associated antigen 3 (LFA-3) in the buccal mucosa of OLP patients 
and compared it with that of healthy controls so as to investigate the possible role of 
LFA-3 in cell interactions within OLP lesions. LFA 3 is a surface antigen with broad 
tissue distribution and mediates T lymphocytes binding via CD2 receptor (LFA2). 
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Interaction between LFA3 and T cell activation enhances the immune response. LFA-3 
was expressed on keratinocytes, LC within the epithelium and on endothelial cells in the 
lamina propria. They have observed that expression of LFA-3 is apparently elevated 
within OLP lesions. LFA-3 may play an important role in the pathogenesis of OLP. 
Porter SR, Kirby A, Olsen I (1997)49 hypothesized the immunological 
mechanism associated with LP. They suggested that the numbers of LC might be normal 
or increased. These cells may be more dentritic in LP than in normal mucosa, suggesting 
an increase in surface antigen expression or elevated dendritic growth. There is a 
significant increase in HLA-DP and HLA-DQ and perhaps HLA-DR expression is 
possibly induced by local cytokine production. LC in LP often appear to accumulate in 
groups of several cells close to the basal cell layer and might be highly involved in the 
presentation of antigen to infiltrating T lymphocytes. 
McCartan BE and Lamey PJ (1997)41 showed that the numbers of LC 
expressing the common thymocyte antigen (T6/CD1) are similar in OLP and in normal 
oral epithelium; however, expression of class II major histocompatibility antigens (HLA-
DR/Ia) by LC is greater in LP than in normal epithelium, a phenomenon believed to be 
associated with activation and antigen presentation. Six patients with LDE and LP were 
studied. An immunoperoxidase technique was used to demonstrate binding of T6 and 
HLA-DR antibodies to identify dendritic intraepithelial cells as LC and activated LC, 
respectively. In LDE, the number of HLA-DR + ve LC was significantly lower than the 
number of T6 + ve LC (P < 0.05). 
 In LP, the initiation of this process appears to be permeation by antigens into the 
oral epithelium followed by entrapment of these transepithelial antigens by LC. The LC 
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is immunocompetent dendritic cells that form a plexus within the epithelium & are also 
found in the dermis or lamina propria. They process antigens to CD4 lymphocytes that in 
turn may activate CD8 lymphocytes which may be responsible for basal cell damage.41 
 In LM, associated with systemic drug administration, the route of access of the 
antigen to the immune system is unlikely to be directly across the epithelium but 
probably involves a more remote site of antigen processing & presentation, which leads 
to reduction of LC.  The results provide evidence for differences in the routes of antigen 
presentation in LDE and OLP41 
McCartan BE and McCreary CE (1997)42 proposed that LC play an important 
role in initiation of inflammatory process in LP. The unidentified antigens are trapped 
within the epidermis by a plexus of interdigitating LC and subsequently presented by LC 
to T lymphocytes. Expression of HLA-DR antigens by LC has been considered to be an 
evidence of activation. 
Walton LJ, Macey MG, Thornhill MH et al (1998)66 questioned of whether 
there is selective recruitment and distribution of intra-epithelial leucocytes in lesions of 
OLP.  They demonstrated changes in intra-epithelial T lymphocyte and LC populations 
compared with normal oral mucosa and suggest that there is a selective recruitment in 
OLP. In addition, keratinocyte ICAM-1 expression does appear to be associated with 
accumulation of infiltrating T lymphocytes and LC. 
  Laine J, Happonen RP, Konttinen YT et al (1999) 37 studied inflammatory cells 
in amalgam-associated, oral lichenoid contact lesions (OLL) in 19 patients by 
immunocytochemistry using monoclonal antibodies. Ten of the patients displayed 
allergic patch test (PT) reactions to several mercury compounds and nine were negative. 
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The number of HLA-D/DR-positive dendritic cells and CD1a-positive LC was 
significantly lower in the PT-negative than PT-positive patients. HLA-D/DR expression 
on keratinocytes varied from negative to full thickness staining of the epithelium. These 
patients also showed a good clinical response after amalgam removal. Consequently, 
OLL may represent a true delayed hypersensitivity reaction with a trans-epithelial route 
of entrance of the metal haptens released from dental restorative materials. 
Katou F, Ohtani H, Saaristo A et al (2000)29 investigated the phenotypic 
characteristics of LC & their relationship with infiltrating lymphocytes. The dermal LC 
abundantly expressed CD83, a marker of mature dendritic cell.  Furthermore these dermal 
LC were in close contact with CD45RO lymphocytes, suggesting that LC could stimulate 
neighboring memory CD4 T cells. 
Hasseus B, Jontell M, Brune M et al (2001)24 compared the expression of 
CD1a+, CD80+ and CD86+ cells in the epithelium of OLP and cGVHD lesions, which 
had the dendritic morphology of LC. Higher frequencies of CD1a+ LC as well as CD25+ 
cells were observed in the OLP epithelium than in the cGVHD epithelium. The OLP 
lesions showed higher frequencies of subepithelial cells expressing CD1a, CD86, CD4, 
CD8 and CD25 than the cGVHD lesions. In conclusion, cGVHD and OLP show marked 
differences at the cellular level despite similar clinical appearance. Hence, the findings 
indicate differences in the regulation of the inflammatory response between the two 
conditions. 
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Villarroel DM, Correnti M, Delgado R et al (2001)63 concluded that the 
immunological reaction begins with LC activation, which presents an antigen to CD4+ 
lymphocytes. Those cells through ICAM-1 and LFA-1 promote epithelial destruction. 
Afterwards, cytokine production, ICAM-1 and VCAM-1 expression can activate CD8+ 
lymphocytes leading to the chronic form of the disease. 
Dorrego VM, Correnti M, Delgado R et al (2002)16 suggested that activated 
epithelia comprise antigen-presenting Langerhans cells, immunocompetent keratinocytes 
and subepithelial inflammatory infiltrate. The presence of a high density of leucocyte 
cells may occur for the expression of a variety of adhesion molecules. They studied 18 
OLP and 10 normal oral mucosa using IHC staining for CD4, CD8, CD1a, LFA-1, 
VCAM-1 and ICAM-1. The results showed an increased number of CD4+, CD8+ and 
CD1a+ cells in OLP. Serial sections showed CD4+ and CD8+ cells also expressed LFA-
1. The expression of ICAM-1 and VCAM-1 were significantly higher in OLP. The 
immunological reaction begins with Langerhans cells activation, which presents an 
antigen to CD4+ lymphocytes. Those cells through ICAM-1 and LFA-1 promote 
epithelial destruction. Afterwards, cytokine production, ICAM-1 and VCAM-1 
expression can activate CD8+ lymphocytes leading to the chronic form of the disease. 
Santoro A, Majorana A, Roversi L et al (2005)54 analysed the presence of 
different dendritic cell (DC) subsets in 16 biopsies from patients with oral lichen planus 
(OLP) using immunohistochemistry. A significant increase of CD1a+/Langerin+ 
Langerhans cells, DC-SIGN+ DC and plasmacytoid DCs (PDCs) were found in the 
epithelium and in the stroma of OLP biopsies compared to normal oral mucosa. A 
proportion of DCs was mature DC and expressed S100 or CD11c, typically found in the 
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interdigitating DCs of nodal T-cell areas. Double staining revealed that mature DCs co-
expressed CCR7, thus indicating the development of a nodal migratory phenotype upon 
maturation. Significant recruitment of PDCs producing IFN-alpha was demonstrated by 
the expression of MxA within the inflammatory infiltrate and close cell-to-cell contacts 
between PDCs and mature DCs were observed, with a significant correlation between the 
numbers of these two populations. Moreover, PDCs were also found to contain 
Granzyme-B, an associated-cytotoxic granule protein, inducing target cell apoptosis. 
They suggested that PDCs might promote maturation of DCs and amplify the cytotoxicity 
of lymphoid cells. Finally, the recruitment of different subtypes of DC, such as 
Langerhans cells, stromal DC-SIGN+ DCs and PDCs, associated with a significant 
proportion of mature DCs, acquiring a CCR7+ 'migratory' phenotype, indicate that they 
may play a pivotal role in the development of the inflammatory infiltrate that occurs 
typically in OLP. 
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ROLE OF T CELLS IN LP & LM 
Takeuchi Y, Tohani I, Kaneda T et al (1988)61 analyzed 
immunohistochemically lymphocytes infiltrating OLP mucosal lesions, particularly in 
satellite cell necrosis (SCN) regions, and cytotoxic/suppressor T lymphocytes were 
predominant in seven of 10 OLP cases. Some carried IL-2 receptors, particularly in SCN. 
Keratinocytes of the mucosal lesions expressed both HLA-ABC and HLA-DR antigens. 
This suggests that activated cytotoxic/suppressor T lymphocytes may play a major role in 
cytotoxicity to keratinocytes as effector cells in OLP. HLA-DR+ and IL-1+ cells, 
vascular endothelial cells and clusters of spindle-shaped or oval cells, which had the same 
surface characteristics as a monocyte macrophage subset, were abundant, and together 
with migrating lymphocytes, might play a role in the immune response in mucosal lesions 
of OLP. 
Walsh LJ, Tseng PW, Savage NW et al (1989)65 studied that CD45R and 
CDw29 antigens are expressed on naive and primed helper T cell populations which 
serve  in suppressor-inducer or helper-inducer functions, respectively. These antigens 
may also be expressed on epithelial cell subpopulations. Monoclonal antibodies reacting 
with T lymphocytes and LC were used to characterize the expression of CD45R and 
CDw29 antigens in OLP. Expression of CD45R was confined to intra-epithelial cells 
with either lymphocytic or dendritic morphology. They demonstrated the existence of 
intra-epithelial cells expressing antigens, which are functionally important in T cell 
responses, which may provide local immunoregulatory influences. 
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Porter K, Klouda P, Scully C et al (1993)48 studied the frequencies of HLA in a 
group of 40 patients with OLP and compared it with those of healthy controls. Alterations 
in the frequencies of several HLA antigens were noted. An increase in HLA– Bw57 and 
decrease in frequency of HLA–DQ 1 were seen in LP. This suggest that LP may 
represent a heterogeneity of disease and that HLA – Bw57 may predispose a person to LP 
whereas HLA – DQ may be associated with resistance to it. 
Walton LJ, Macey MG, Thornhill MH et al (1998)66 studied that the circulating 
'memory' subset (CD45RO+) of T-helper cells (CD4+) was increased from 49.1% in 
controls to 65.7% in patients (P=0.005), while the naive subset (CD45RA+), which was 
absent from control epithelium, comprised 24% of helper cells in OLP (P=0.016). Fewer 
LC expressed CD45RO in OLP than in controls (P=0.037) and all T-cell and LC counts 
were significantly raised in ICAM-1-expressing areas of epithelium. These data 
demonstrate changes in intra-epithelial T-lymphocyte and LC populations compared with 
normal oral mucosa and suggest there is selective recruitment in OLP.  
 Rodriguez-Nunez I, Blanco-Carrion A, Garcia AG et al (2001)52 investigated 
possible immunologic differences between 26 patients with reticular OLP and 26 patients 
with atrophic-erosive OLP. The mean proportions of CD4+CD45RO+ and DR+ 
lymphocytes were significantly higher in patients with atrophic-erosive OLP than in 
patients with reticular OLP. These findings suggest that the two clinical types of OLP 
might have different immunopathogenic mechanisms. 
Zhou XJ, Sugerman PB, Savage NW et al (2002)73 investigated basement 
membrane (BM) disruption & distribution of mast cells and T cells in OLP using 
immunohistochemistry. The number of intra-epithelial CD8 T cells in region of BM 
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disruption was significantly greater than in regions of BM continuity p<0.05. The number 
of CD4 T cells in the epithelium and lamina propria of LP did not vary between regions 
of BM disruption and BM continuity. These data suggest a role for mast cells in epithelial 
BM disruption in LP. CD8 T cells may migrate through BM breaks to enter the OLP 
epithelium. 
Kawamura E, Nakamura S, Sasaki M et al (2003)30 proposed that T-cell 
receptor (TCR) in OLP is one of the most important steps to reveal the pathogenic 
antigen recognized by the T cells and thereby elucidate the pathogenesis and etiology of 
OLP. 7 patients with OLP, the TCR V beta gene usage was examined by polymerase 
chain reaction and single-strand conformation polymorphism analyses. The V beta 
families predominantly expressed in the biopsy specimens, the accumulation of T-cell 
clonotypes was observed in the majority of the V beta families including V beta 6, V beta 
19and V beta 2. These results suggest that unique T-cell populations bearing V beta 2, V 
beta 6, or V beta 19 gene products tend to expand in OLP lesions as a consequence of 
insitu stimulation with a restricted epitope of either a nominal antigen on the MHC 
molecule for the majority of the V beta families, even if only in minor populations, or of 
a common superantigen for the minority of the V beta families. 
Khan A, Farah CS, Savage NW et al (2003)31 described the cell-mediated 
immune responses in OLP, which may be regulated by cytokines and their receptors. 
Immunohistochemistry and ELISA determined cytokine secretion in OLP. Majority of 
subepithelial and intra-epithelial mononuclear cells in OLP was CD8+ and some were 
found adjacent to degenerating keratinocytes. CD4+ cells were observed mainly in the 
deep lamina propria with occasional CD4+ cells close to basal keratinocytes. 
34 
  
Mononuclear cells expressed IFN-gamma in the superficial lamina propria and TNF-
alpha adjacent to basal keratinocytes. TNF R1 was expressed by mononuclear cells and 
basal and suprabasal keratinocytes. These data suggest the development of a T helper1 
immune response that may promote CD8+ cytotoxic T cell activity in OLP. 
Sato M, Tokuda N, Fukumoto T et al (2006)55 studied that cGVHD is a 
common and serious complication after bone marrow transplantation (BMT). The 
immunohistopathological features of cGVHD compared with oral lichen planus (OLP) 
and healthy controls. Results showed that the infiltrations of CD4-positive T cells of 
cGVHD and OLP were significantly larger than those of the normal oral mucosa. A 
larger number of CD8-positive T cells were infiltrated in cGVHD and OLP compared 
with the normal oral mucosa. The difference in the number of CD4- and CD8-positive T 
cells between cGVHD and OLP was not significant. The infiltrations of LC (CD1a) in 
cGVHD and OLP were significantly larger than in the normal oral mucosa. The 
difference in the number of LC between cGVHD and OLP was not significant. It is 
suggested that LC and CD8-positive T cell may play a major role in the pathogenesis of 
the oral lichenoid lesions of cGVHD, and the immune response was inducted in OLP as 
well as the oral lichenoid lesion of cGVHD in this study. 
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Materials & Methods 
 
 
 
 
  
Study design: 
The study was designed to record the clinical details of patients with OLP & LM, 
and to study the LC & T cell population using immunohistochemical procedures. 
Study setting: 
       The study was conducted in the department of Oral and Maxillofacial Pathology, 
Ragas dental college and hospital, Chennai. 
Study subject: 
 15 cases of OLP & 15 cases of LM were selected. A predetermined clinical case 
sheet was used to record all the cases. Detailed case history including age, sex, 
occupation, past medical history and dental history with history of habits, drugs & 
traumas were recorded. This is followed by general examination & intraoral examination.  
Clinically appearing bilateral white lesion having the characteristic Wickham’s 
striae with or without dermatological manifestation was considered as LP.  As the clinical 
features of LP & LM are similar, white lesions with bilateral distribution were 
categorized as LP and those with unilateral distribution as LM clinically. Informed 
consent was taken from all cases of OLP & LM prior to the biopsy procedure.  
However, the final diagnosis was based on histopathological features in which 
dense band of inflammatory cells predominantly consists of lymphocytic infiltrate, 
confined to subepithelial region, hyperkeratosis and basal cell liquefaction28. 
The histopathological findings of LM differ from LP. In LM areas show mixed 
inflammatory cell response with lymphocytes, eosinophils and plasma cells, which is 
more diffuse & extends to deeper region42.  
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Controls: 
Biopsies from the 10 patients were taken from normal buccal mucosa adjacent to 
the site of surgery during the surgical removal of third molar or from patients who 
underwent orthodontic extractions after the informed consent (Fig 5). All the patients 
were in good general health and none of them had taken anti-microbial or anti-
inflammatory drugs within the previous 3 months.  
Tissue specimens: 
Incisional biopsy of sufficient width and depth to ensure inclusion of connective 
tissue was taken from buccal mucosa. The tissue taken was immediately transferred to 
10% buffered formalin for further processing. After adequate fixation paraffin blocks of 
tissue were made. From the blocks, 5-micron thick sections were cut and used for routine 
haematoxylin and eosin (H & E) staining and immunohistochemical staining using biotin 
streptavidin methods. (CD45RO and CD1a monoclonal antibody)  
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IMMUNOHISTOCHEMISTRY (IHC): 
Armamentarium for IHC 
1. Aluminum foil 
2. APES coated slides 
3. Autoclave 
4. Beakers 
5. Coplin jars 
6. Cover slips 
7. Cyclomixer 
8. Electronic timer 
9. Hot air oven 
10. Light microscope 
11. Measuring jar 
12. Micropipettes 
13. Pasteur pipettes 
14. Rectangular steel trays with glass rods 
15. Refrigerator 
16. Microtome 
17. Slide carrier 
18. Slide warmer 
19. Sterile gauze 
20. Tooth forceps 
21. Weighing machine (DHONA 200D) 
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Reagents: 
1. Distilled water 
2. Laxbro solution 
3. 1 N Hydrochloric acid 
4. APES (3-amino propyl tri ethoxy silane) 
5. Acetone 
6. Xylene 
7. Absolute alcohol 
8. Alcohol 70% 
9. Hydrogen peroxide 3% 
10. Citrate buffer (pH 6) 
11. Phosphate buffer saline (pH 7) 
12. Hematoxylin 
13. Ammonia 
14. DPX 
 
Antibodies: 
• DAKO TM  Monoclonal mouse anti human CD1a , Clone (01∅)  
• DAKO TM  Monoclonal mouse anti human CD45RO, Clone (UCHL1)  
• DAKO TM   LSAB 2 KIT/ HRP  
¾ Biotinylated Link 
¾ Streptavidin  Peroxidase 
¾ Chromogen DAB  (3 Diaminobenzidine Tetrahydrochloride)  
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Before taking the sections on to the slides, all the slides were APES coated. 
Precoating procedure of the slides was as follows:  
 
Pretreatment of the slides 
• The slides were first washed in tap water for few minutes 
• They were then soaked in detergent solution for 1 hour 
• After 1 hour, each slide was brushed individually using the detergent solution and 
then transferred to distilled water. 
• Slides were washed in two changes of distilled water. 
• Later slides were again washed in autoclaved distilled water. 
• The slides were then immersed in 1 N HCL (100 ml HCL in 900 ml distilled 
water) overnight. 
• The following day, slides were taken out of acid and washed in two changes of 
autoclaved distilled water. 
• All the slides were then transferred to slide trays, wrapped in aluminium foil and 
baked in hot air oven for 4 hours at 180 degrees centigrade. 
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APES (3 Amino propyl tri ethoxy silane) coating: 
 
        Slides were first dipped in  a coupling jar-containing acetone for 2 minutes 
 
                Dipped in APES for 5 minutes 
 
            Dipped in two changes of distilled water for 2 minutes 
                 
            Slides were left to dry 
 
Preparation of paraffin sections 
After the slides were dry, tissue section of 0.5-micron thickness were made in a 
rotary manual microtome. The ribbons of tissue section were transferred onto the APES 
coated slide from the tissue float both such that two tissue bits come on to the slide with a 
gap in between. One of the tissue sections was labeled positive (P) and the other negative 
(N). Circles were drawn with a glass-marking instrument around the tissue, so that the 
antibodies were localized in the area of interest. 
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IHC procedure flow chart: CD1a & CD45RO Antibody 
APES coated slides with paraffin embedded tissue 
 
Placed in xylene I (8 minutes) 
 
Placed in xylene II (10 min) 
 
Placed in 100% isopropanol (5min) 
 
Placed in 70% isopropanol (5min) 
 
Washed in distilled water twice (5 min each) 
 
Placed in 0.3% hydrogen peroxide (20 min) 
 
Washed in distilled water twice (5 min each) 
 
Kept in citrate buffer and autoclaved 
 
Washed in distilled water twice (5 min each) 
 
Washed in PBS (5 min) 
 
  Primary antibody added & incubated for 1 hr at room temperature (CD1a & CD45RO) 
 
Washed in PBS thrice (5 min each) 
 
                 Secondary antibody (biotinylated link) was added (20 min) 
 
Washed in PBS thrice (5 min each) 
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     Streptavidin was added & incubated (20 min) 
 
Washed in PBS thrice (5 min each) 
 
     DAB was added and incubated (5 min) 
 
Washed in distilled water (5 min) 
 
      Stained with haematoxylin (30 seconds) 
 
Washed in distilled water 
 
         Placed in ammonia (1 min) 
 
Washed in distilled water 
 
Placed in 70% isopropanol (3 dip) 
 
Placed in 100% isopropanol (3dip) 
 
Placed in xylene I (1 dip) 
 
Placed in xylene II (2 dip) 
  
Slides were mounted using DPX 
 
    Slides were observed under the microscope 
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Immunohistochemistry procedure 
The slides with tissue sections were treated with two changes of xylene to remove 
paraffin wax. They were put in descending grades of alcohol and then rehydrated with 
water. Slides were then treated with 3% hydrogen peroxide for 20 minutes to quench 
endogenous peroxidase activity of cells that would otherwise result in nonspecific 
staining. The slides were then put in two changes of distilled water.  
The slides were then transferred to citrate buffer and autoclaved for antigen 
retrieval at 15 lbs pressure for 15 minutes. The slides were then washed in two changes of 
distilled water. Then the slides were dipped in PBS for 5 minutes, and then wiped 
carefully with gauze to remove excess PBS. Circles were drawn around the tissues, so 
that the antibodies added later on do not spread and are restricted to the circle. The 
primary antibody CD45RO & CD1a (DAKO) was added separately to P tissue on the 
slide and PBS was added to the N tissue. The petridish containing the slides was kept at 
room temperature for 1 hour.  
The sections taken out were washed in three changes of cold PBS for 5 minutes 
each to remove the excess antibody. Then the slides were wiped carefully without 
touching the tissue section to remove excess PBS. Then a drop of Biotinylated link from 
the secondary antibody kit (DAKO LSAB 2KIT) was added on both the sections and the 
slides incubated for 20 minutes. Later the slides were washed in three changes of cold 
PBS for 5 minutes each. The slides were again wiped carefully without touching the 
tissue section to remove excess PBS. Then a drop of Streptavidin from the secondary 
antibody kit (DAKO LSAB 2KIT) was added on both the sections and the slides 
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incubated for 20 minutes. The sections were then washed in 3 changes of cold PBS for 5 
minutes each. Then the slides were again wiped carefully to remove excess PBS.  
Then a drop of freshly prepared DAB (3’– Diamino benzidine tetra hydrochloride 
– a substrate chromogen) was added on to both sections. Slides were then washed in 
running distilled water to remove excess DAB and counter stained with haematoxylin. 
The slides were dipped in ammonia for one minute for blueing. Then the slides were 
transferred to 70% alcohol, 100% alcohol and two changes of xylene. The tissue sections 
were mounted with DPX. Slides were then observed under the microscope. Throughout 
the procedure care was taken not to dry the tissues. 
Analysis of CD1a & CD45RO expression was done by evaluating the positive 
cells. CD1a positive cell showed staining pattern as membranous and weakly 
cytoplasmic. CD45RO positive cell showed membranous staining (as recommended by 
product specification).  
Analysis of CD1a expression by evaluating the labeling index (LI) for each slide 
was calculated by dividing the number of positive cells by the total number of cells 
counted in the slide and expressed as percentage. A total of thousand cells were counted 
in each slide.                                  Number of positive cells        
                       LI   =   ---------------------------------------- × 100 
                                                          1000 
Analysis of CD1a & CD45RO expression was done by evaluating the staining 
intensity. Slides were assessed for mild (+), moderate (++), intense (+++), or no 
expression (-). 2 investigators using Kappa statistics compared CD1a and CD45RO 
antibody staining intensity between the study groups. Kappa statistics was done for 
interpretation of the inter-observer variation. 
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Statistical Analysis  
 
  
 
STATISTICAL ANALYSIS 
Data entry and analysis was performed using SPSS version 10.0.5®. Mean LI and 
standard deviation was calculated to assess CD1a expression and percentage of intensity 
was calculated to assess CD1a & CD45RO expression.   
• Student t-test was done to compare the descriptive variables between the study 
groups. 
• Analysis of variance (ANOVA) was done to compare the mean LI of CD1a 
between LP, LM and NM. 
• Bonferroni test of multiple comparison test was done to compare the LI of CD1a 
between LP, LM and NM. 
• Kappa statistics for the inter-observer variation of CD1a and CD45RO antibody 
staining intensity between the study groups. 
• Chi-square test was done to compare the percentage expression of CD1a & 
CD45RO between LP, LM and NM. 
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Results 
 
 
 
    
  
 This study was to compare the clinical and histopathological features of LP and 
LM and evaluate LC and T cells number and activity using monoclonal antibody CD1a 
and CD45RO. 
  Of the 15 cases of LP 10 were females and 5 were males. The mean age was 36 
years ± 17 for males and 44 years ± 12 for females. All 15 cases involved the buccal 
mucosa. In addition to buccal mucosa, the alveolar mucosa was affected in 2 cases and 
gingiva in 1 case. 12 cases showed a bilateral distribution and 3 cases had a unilateral 
distribution. (Table 1).  
  Of the 15 cases of LM 10 were females and 5 were males. The mean age was 38 
years ± 17 for males and 40 years ± 11 for females. 9 out of 15 cases occurred in buccal 
mucosa, 5 cases had lesions in tongue, 3 cases in alveolar mucosa and 4 cases in gingiva. 
1 case showed a bilateral distribution and all other 14 cases had a unilateral distribution 
(Table 1). 
  Of the 10 cases of NM 3 were females and 7 were males. The mean age was 40 
years ± 15 for males and 24 years ± 5 for females. In 7 out of 10 cases, biopsy was taken 
from buccal mucosa and 3 cases from gingiva as control. (Table 1) 
  Among the 15 cases of LM, 8 (53.33%) cases had drug history of NSAID drug 
intake and 3 (20%) cases had antihypertensive drugs, 2 (13.33%) cases had hypoglycemic 
drug and 1 (6.67%) case had tetracycline. 1 case (6.67%) had multiple amalgam fillings 
(Table 2). 
Age and gender analysis among the study group (LP, LM & NM) were not 
statistically significant (LP p = 0.27, LM p = 0.15, NM p = 0.43) (Table 3). 
CD1a antibody Mean Labeling Index between the study groups: 
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 The Mean Labeling Index in basal layer of LP was 5.31 with a standard deviation 
(SD) of 2.26 (Fig 6 & 7); in LM it was 2.36 with a SD of 2.17 (Fig 8 & 9) and in NM it 
was 0.87 with a SD of 0.65 (Fig 10 & 11). The difference in mean LI between the study 
groups for basal layer was statistically significant (p = 0.00) (Table4, graph 1). 
The Mean Labeling Index in supra basal layer of LP was 6.36 with a standard 
deviation (SD) of 3.24; in LM it was 3.54 with a SD of 2.70 and in NM it was 0.80 with a 
SD of 0.44. The difference in mean LI between the study groups for supra basal layer was 
statistically significant (p = 0.00) (Table4, graph 1). 
  The Mean Labeling Index in the connective tissue of LP was 62.67 with a 
standard deviation (SD) of 43.92; in LM it was 18.0 with a SD of 10.99and in NM it was 
5.30 with a SD of 2.67.The difference in mean positive cells between the study groups for 
connective tissue layer was statistically significant (p = 0.00) (Table4, graph 2). 
Mean difference in CD1a antibody Mean Labeling Index between the study groups 
(Bonferroni Test): 
 The Mean difference in Mean Labeling Index in basal layer of LP and LM was 
2.96 and it was statistically significant (p = 0.001); in LP and NM was 5.54 and it was 
statistically significant (p = 0.00); in LM and NM was 1.49 and it was statistically not 
significant (p = 0.21). 
 The Mean difference in Mean Labeling Index in supra basal layer of LP and LM 
was 2.82 and it was statistically significant (p = 0.016); in LP and NM was 5.55 and it 
was statistically significant (p = 0.000); LM and NM was 2.73 and it was statistically 
significant (p = 0.043).  
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The Mean difference in Mean Labeling Index in connective tissue layer of LP and 
LM was 44.67 and it was statistically significant (p = 0.000); in LP and NM was 57.37 
and it was statistically significant (p = 0.00); in LM and NM was 12.70 and it was 
statistically not significant (p = 0.815) (Table 5). 
2 investigators using Kappa statistics compared CD1a and CD45RO antibody 
staining intensity between the study groups. Kappa statistics for the inter observer 
variation was between 0.6-0.8, and the agreement between the 2 evaluators was 
statistically significant in all the layers (p < 0.05) (Table 6). 
CD1a antibody staining intensity between the study groups:  
The staining intensity in the basal layer of LP, 2(13.3 %)cases showed no 
staining, 8(53.3%) cases mild staining, 1(6.7%) case moderate and 4(4.0%) cases were 
intensely stained. In LM, 3(20%)cases showed no staining, 9(60 %) cases mild staining, 
3(20%) cases were moderately stained. In NM, 1(10 %) case showed no staining, 8(80%) 
cases mild staining and 1(10%) case was moderately stained. The difference in staining 
intensity pattern between the study groups was not statistically significant (p = 0.176) 
(Graph3) 
In the supra basal layer of LP, 3(20%) cases showed no staining, 4(26.7 %) cases 
mild staining, 7(46.7%) cases moderate staining and 1(6.7%) case was intensely stained. 
In LM, 2(13.3%) cases showed no staining, 10(66.7%) cases mild staining and 3(20%) 
cases were moderately stained. In NM, 2(20%) cases showed no staining, 4(40%) cases 
each showed mild and moderate staining. The difference in staining intensity pattern 
between the study groups was not statistically significant (p = 0.39) (Graph 4).               
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  In the connective tissue of LP, 5(33.3%) cases showed mild staining, 7(46.7%) 
cases moderate and 3(20%)cases were intensely stained. In LM, 3(20%) cases showed no 
staining, 5(33.3%) cases mild staining and 7(46.7%) cases were moderately stained. In 
NM, 4(40%) cases showed no staining and 6(60%) cases were showed mild staining. The 
difference in staining intensity pattern between the study groups was statistically 
significant (p = 0.011) (Graph 5). 
 The staining intensity pattern of CD1a antibody of basal and suprabasal layers of 
epithelium and connective tissue is given in (Table 7, Graph 6).  
CD 45 RO antibody mean percentage staining intensity between the study groups:  
In the connective tissue of LP, 1(6.7%) case showed mild staining, 6(40%) cases 
moderate and 8(53.3%) cases showed intense staining (Fig 12 & 13). In LM, 5(33.3%) 
cases showed mild staining, 7(46.7%) cases moderate staining and 3(20%) cases were 
intensely stained (Fig 14 & 15). In NM, 1(10%) case showed no staining, 6(60%) cases 
mild staining and 3(30%) cases were moderately stained (Fig 16 & 17). The difference in 
staining intensity pattern between the study groups was statistically significant (p= 0.014) 
(Table 8, Graph 7). 
CD1a and CD45RO antibody staining intensity between the study groups:  
In the connective tissue, the difference in staining intensity pattern between the 
study groups was not statistically significant. (Table 9, Graph 8). 
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    Tables & Graphs 
 
  
EVALUATION OF T CELLS & LANGERHANS CELL IN LICHEN PLANUS & 
LICHENOID MUCOSITIS 
Table 1: Age, gender and site, distribution among the study groups 
   
 
Sex Age Site Distribution 
 
  
 
  Lesion M F M F 
Buccal 
mucosa 
Tongue 
Alveolar 
mucosa 
Gingiva Bilateral Unilateral 
Lichen           
planus 5 10 36 ± 17 44 ±12 15 - 2 1 12 3 
Lichenoid 
mucositis 5 10 38 ± 17 40 ±11 9 5 3 4 1 14 
Normal 
mucosa 
7 3 40 ± 15 24 ± 5 7 - - 3 - - 
 
 
 
Table 2: Systemic drug intake and contact allergens among the LM study groups 
 
 
 
Drug & contact allergens n (15) % 
NSAIDS 8 53.33 
Antihypertensive drug 3 20.00 
Hypoglycemic drug 2 13.33 
Antibiotic (Tetracycline)  1 6.67 
 Multiple Amalgam fillings 1 6.67 
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Table 3: Age & gender distribution between the study groups 
 
Male Female 
Age groups 
n % n % 
p value 
Lichen Planus  
       <25 
       25 - 34 
       35 – 44 
       45 – 54 
       >55 
    1 
    - 
- 
3 
- 
     25.0 
       - 
- 
75.0 
- 
      2 
      - 
4 
3 
2 
     18.2 
- 
36.4 
27.3 
18.2 
.270 
Lichenoid Mucositis  
      <25 
       25 - 34 
       35 – 44 
       45 – 54 
       >55 
 
1 
2 
- 
1 
1 
 
20.0 
40.0 
- 
20.0 
20.0 
 
- 
3 
5 
- 
2 
 
- 
30.0 
50.0 
- 
20.0 
.159 
Normal Mucosa 
       <25 
       25 -34 
       35 – 44 
       45 – 54 
       >55 
 
1 
2 
2 
3 
- 
 
12.5 
25.0 
25.0 
37.5 
- 
 
1 
1 
- 
- 
- 
 
50.0 
50.0 
- 
- 
- 
.439 
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Table 4: CD1a antibody mean labeling index between the study groups 
 
 
 n Mean p value 
Basal cells 
            Lichen planus 
            Lichenoid mucositis 
          Normal mucosa 
 
15 
15 
10 
 
5.31 ± 2.26 
2.36 ± 2.17 
0.87 ± 0.65 
 
 
.000** 
Supra basal cells 
            Lichen planus 
            Lichenoid mucositis 
          Normal mucosa 
 
15 
15 
10 
 
6.36 ± 3.24 
3.54 ± 2.70 
0.80 ± 0.44 
 
 
.000** 
Connective tissue • 
            Lichen planus 
            Lichenoid mucositis 
          Normal mucosa 
 
15 
15 
10 
 
62.67 ± 43.92 
18.00 ± 10.99 
5.30   ± 2.67 
 
 
.000** 
 
 
• Mean positive cells      ** p < 0.01 Statistically significant                                         
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Table 5: Mean difference in CD1a antibody mean labeling index between the study 
groups 
 
 
 
Study groups Mean difference p value 
 
Basal layer                Lichen planus 
                                  Lichenoid mucositis 
 
                                  Lichen planus 
                                  Normal mucosa 
 
                                  Lichenoid mucositis 
                                  Normal mucosa 
                  
 
        2.96 
 
 
        4.45 
 
 
        1.49 
     
   .001** 
 
 
   .000** 
 
 
    210 
  
Supra Basal layer     Lichen planus 
                                   Lichenoid mucositis 
 
                                   Lichen planus 
                                   Normal mucosa 
 
                                   Lichenoid mucositis 
                                   Normal mucosa 
                  
 
        2.82 
 
 
       5.55 
 
 
       2.73 
 
   .016* 
 
 
   .000** 
 
 
    .043* 
  
Connective tissue      Lichen planus 
                                   Lichenoid mucositis 
 
                                   Lichen planus 
                                   Normal mucosa 
 
                                   Lichenoid mucositis 
                                   Normal mucosa 
                  
 
      44.67 
 
 
      57.37 
 
 
      12.70 
 
   .000** 
 
 
   .000** 
 
 
   .815 
 
 
** p < 0.01     Statistically significant 
*   p < 0.05     Statistically significant 
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Graph 1: CD1a antibody mean labeling index of basal & suprabasal epithelial layer 
between the study groups 
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Graph 2:  CD1a antibody mean positive cells of connective tissue between the study 
groups 
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Table 6: Kappa statistics - For CD1a & CD45 RO antibody staining intensity 
 
 
 
                     Lichen planus Lichenoid mucositis 
 
Normal mucosa 
 
  
CD1a        Basal  
                  Supra basal  
                  Connective tissue  
 
0.71 
0.68 
0.67 
 
0.73 
0.57 
0.68 
 
0.58 
0.69 
0.78 
 
CD45RO   Connective tissue 
 
0.75 
 
0.78 
 
0.64 
 
 
 
 
 Agreement between two evaluators is statistically significant in all the layers p < 0.05 
56 
  
Graph 3: CD1a antibody staining intensity of the basal layer between the study 
groups 
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Graph 4: CD1a antibody staining intensity of the supra basal Layer between the 
study  groups 
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Graph 5: CD1a antibody staining intensity of the connective tissue between the 
study groups 
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p value 0.011
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Table 7: CD1a antibody staining intensity of the basal, supra basal layer & connective tissue between the study groups 
 
 
 
 
*  p < 0.05     Statistically significant 
- Negative 
+ Mild 
++ Moderate  
+++  Intense  
                 Basal n (%)            Supra basal n (%)              Connective tissue n (%) Lesion 
- + ++ +++ - + ++ +++ - + ++ +++ 
 
Lichen 
planus 
 (n 15) 
2 
(13.3%) 
8  
(53.3%) 
1 
 (6.7%) 
     4 
(26.7%) 
3  
(20%) 
4 
(26.7%) 
7 
(46.7%) 
1 
(6.7%) - 
5 
(33.3%) 
7 
(46.7%) 
3 
(20%) 
Lichenoid 
mucositis 
 (n 15) 
3 
(20%) 
9 
(60%) 
3 
(20%) - 
2 
(13.3%) 
10 
(66.7%) 
3 
(20%) - 
3 
(20%) 
5 
(33.3%) 
7 
(46.7%) - 
Normal 
mucosa 
 (n 10) 
1 
(10%) 
8 
(80%) 
1 
(10%) - 
2 
(20%) 
4 
(40%) 
4 
(40%) - 
4 
(40%) 
6 
(60%) - - 
  
p value 
 
.176 
 
.394 
 
.011* 
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Graph 6: CD1a antibody staining intensity of the basal, supra basal layer & connective tissue between the study groups 
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Table 8: CD45RO antibody staining intensity of the connective tissue between the 
study groups. 
 
 
                 Connective tissue n (%) 
 
 
 
          Lesion - + ++ +++ 
  
 
      p value 
 
Lichen planus  
(n 15) 
 
     - 
 
 1 (6.7%) 
 
6 (40.0%) 
 
8 (53.3%) 
 
Lichenoid 
mucositis (n 15) 
 
     - 
 
5 (33.3%) 
 
7 (46.7%) 
 
3 (20.0%) 
 
Normal mucosa 
(n 10) 
 
 1 (10.0%) 
 
6 (60.0%) 
 
3 (30.0%) 
 
       - 
 
      
 
         .014* 
 
*   p < 0.05     Statistically significant 
 
 
 
Graph 7: CD45RO antibody staining intensity in connective tissue between the 
study groups 
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Table 9: CD45RO & CD1a antibody staining intensity in connective tissue between 
the study groups 
 
 
CD45RO n (%) CD1a n (%) Lesion - + ++ +++ - + ++ +++ 
   p 
value 
 
 
Lichen 
planus  
(n 15) 
 
0 
 
1 
(6.7%) 
 
6 
(40%) 
 
8 
(53.3%) 
 
0 
 
5 
(33.7%) 
 
7 
(46.7%) 
 
3 
(20%) 
 
.081 
 
Lichenoid 
mucositis 
(n 15) 
 
0 
 
5 
(33.3%) 
 
7 
(46.7%) 
 
3 
(20%) 
 
3 
(20%) 
 
5 
(33.3%) 
 
7 
(46.7%) 
 
0 
 
.112 
 
Normal 
mucosa 
  (n 10) 
 
1 
(10%) 
 
6 
(60%) 
 
3 
(30%) 
 
0 
 
4 
(40%) 
 
6 
(60%) 
 
0 
 
0 
 
 
.091 
 
 
 
 
Graph 8: CD45RO & CD1a antibody staining intensity in connective tissue between 
the study groups 
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Photomicrographs 
  
 
Figure 1 Lichen Planus  
 
 
 
 
 
Figure 2 Lichenoid Mucositis 
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Figure 3 Photomicrograph of Lichen Planus H&E (10x)  
 
 
 
 
 
 
 
Figure 4 Photomicrograph of Lichenoid Mucositis H&E (10x) 
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Figure 5 Photomicrograph of Normal Mucosa H&E (10x) 
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Figure 6 Photomicrograph of CD1a expression in Lichen Planus (10x) 
 
 
 
 
 
 
 
Figure 7 Photomicrograph of CD1a expression in Lichen Planus (40x) 
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Figure 8 Photomicrograph of CD1a expression in Lichenoid Mucositis (10x) 
 
 
 
 
 
 
 
Figure 9 Photomicrograph of CD1a expression in Lichenoid Mucositis (40x) 
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Figure 10 Photomicrograph of CD1a expression in Normal Mucosa (10x) 
 
 
 
 
 
 
 
Figure 11 Photomicrograph of CD1a expression in Normal Mucosa (40x) 
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Figure 12 Photomicrograph of CD45RO expression in Lichen Planus (10x) 
 
 
 
 
 
 
Figure 13 Photomicrograph of CD45RO expression in Lichen Planus (40x) 
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Figure 14 Photomicrograph of CD45RO expression in Lichenoid Mucositis (10x) 
 
 
 
 
 
 
Figure 15 Photomicrograph of CD45RO expression in Lichenoid Mucositis (40x) 
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Figure 16 Photomicrograph of CD45RO expression in Normal Mucosa  (10x) 
 
 
 
 
 
 
Figure 17 Photomicrograph of CD45RO expression in Normal Mucosa  (40x) 
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Discussion  
 
 
  
Lichen planus (LP) is a common mucocutaneous disease. It was first described by 
Erasmus Wilson in 1869 and is thought to affect 0.5- 1% of the world’s population. The 
condition can affect either the skin or the mucosa or both44. It often affects the oral 
mucosa and may occur without skin lesions. About 50% of the patients with skin lesions 
have oral lesions28. 
LP represents a cell mediated immunological response to an induced antigenic 
change in skin or mucosa28. A wide variety of drugs have been associated with 
precipitating LP like eruptions and this phenomenon has been termed as Lichenoid Drug 
Eruption (LDE). Though individual drugs may be involved, multiple systemic drug 
therapy, topical agents and contact allergens may also be involved, perhaps by a 
synergistic action on the host immune system and precipitate LDE. These LDE occurring 
in oral mucosa are termed as Lichenoid Mucositis (LM) 38. 
Because LM can resemble LP clinically and histopathologically, it is not always 
possible to conclude that a drug has induced LP or LM. Furthermore the identification of 
the offending drug can be complicated by the factors such as simultaneous exposure to 
several drugs, drug interactions and variability in the latent period between intake of the 
drug and appearance of the eruptions23. 
The mean age of the patient with LP was reported by Fellner and Halevy  (1993) 
to be 47 yrs and 49 yrs respectively .The mean age of the patient for LM according to 
West et al (1990) & Halevy (1993) was 57 & 66 yrs respectively23. In our study the 
mean age of 15 patients with LP was 36(± 17) yrs for males & 44(± 17) yrs for females 
and for the 15 patients with LM, it was 38(± 17) yrs for males & 40(± 11) yrs for 
females. There was only a minimal difference between the mean age of patients with LP 
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and LM when compared with the studies cited above. This shows that LM could occur in 
people of younger age groups. 
Jungell P (1991)28 reported that 60-65 % of patients affected by LP are females. 
Kovesi G and Banoczy J (1973)34 studied 326 patients with LP & reported  that 63% had 
female predominance. Lamey PJ et al (1995) 38 studied 161 patients of LM out of which 
119 were females. In our present study out of 15 cases, 10 were females and 5 were 
males in both LP & LM. This finding of female predilection was found to be similar with 
the previous studies. In our study among the groups (LP, LM, NM) we did not observe 
any significant difference in the age and gender distribution.  
In our study the common site of occurrence of LP was buccal mucosa followed by 
alveolar mucosa & gingiva and this finding is consistent as the site reported by Jungell P 
(1991)28 & Mollaoglu N (2000)44. Similarly the common site of LM reported by Myer 
SL et al (2002)45 was buccal mucosa, which is consistent with our study as 9 cases 
occurred in buccal mucosa and other sites were reported in tongue, alveolar mucosa and 
gingiva. 
Jungell P (1999)28, Mollaoglu N (2000)44, Chainami Wu (2001)9 reported cases 
of LP in the buccal mucosa showing bilateral distribution. In our study 12 (80%) cases 
showed bilateral distribution. LP generally has a period of remission and exacerbations; 
the possibility of different remission periods between the two sides may have been the 
cause for the unilateral distribution seen in 3 (20 %) of our cases.  
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Halevy (1993)23 & McCartan (1997)42 stated that clinically LM has a unilateral 
presentation. In our study, 14 (93%) cases showed unilateral distribution, which is 
consistent with the previous reports, cited above.  However 1 (6.7%) case in our study 
had multiple amalgam fillings and this case showed bilateral distribution. 
LC plays a major role in the pathogenesis of LP as it recognizes, processes and 
presents the antigen to both helper and cytotoxic T cells specific for protein antigens, 
haptens, and alloantigens39. These dendritic cells initiate immune reactions, and the 
lesions of LP are characterized by sub and intra-epithelial accumulation of T lymphocytes 
associated with basal cell destruction20. 
To identify human LC in the epithelium, the most reliable marker used is CD1a 
(T6) antibody39. We have used this antibody to evaluate LC number and activity in LP, 
LM, NM. We have considered those cells showing membranous and weakly cytoplasmic 
staining pattern as CD1a positive LC cells. 
We observed that the mean CD1a labeling index (LI) for LP was significantly 
higher than that of LM & NM in the basal and supra basal layer. The mean CD1a positive 
cells in the connective tissues for LP was higher than that of LM and NM. The difference 
in mean LI among the study groups showed statistical significance. These observations 
were consistent with that of McCartan et al (1997)41, Regezi et al (1985)50, Laine J et al 
(1999)37, who reported statistically significant higher number of LC in LP. However they 
did not observe significant difference of CD1a LI between the different layers of the 
epithelium of LP.  
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Eversole et al (1994)17 and Farthing PM et al (1990)20 observed dendritic cells 
in both the epithelium and the underlying connective tissue, involved in antigen 
processing and presentation to CD4 helper lymphocytes in LP.  
LC in OLP has been shown to be either increased in number or activated 
indicating the preparation for boosted antigen presentation37. Absolute numbers of LC in 
normal and diseased tissues are difficult to establish because the number of LC vary from 
one oral focus to another and from one patient to another50. Not all the results are 
comparable as a variety of staining techniques and counting techniques have been 
employed: including counting per mm of basal layer, counting per mm of epithelial 
surface, per mm2 of epithelium and per high power field direct counts and counts from 
photomicrographs 41. 
Regezi el al (1985)50 postulated that although there was an actual influx of 
additional LC into the epithelium in active state of LP, it could be argued that this may be 
more apparent than real. Increased metabolic activity and antigenic challenge could 
account for greater production of HLA-DR antigen expression in resident LC without real 
influx of LC. In our study, there was a significant difference in the mean difference CD1a 
LI between LP and LM in basal, supra basal layers of epithelium and in the connective 
tissue.  
McCartan et al (1997)41 concluded that in OLP the initiation of the process 
appears to be permeation of antigens into the oral epithelium followed by the entrapment 
of the trans-epithelial antigen by LC. In LM associated with systemic drug 
administration, the route of access of the antigen to the immune system is unlikely to be 
directly across the epithelium but probably involves a remote site of antigen processing 
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and presentation, which would be expected to result in reduced number of LC in the oral 
epithelium. In our study also our findings indicated decreased number of LC in LP than 
LM, as established by mean CD1a LI. The reduced LC count in LM as compared with LP 
argues for two different routes of antigen presentation and processing41.  
 In our study we evaluated the mean difference in mean CD1a LI between LM 
and NM. The mean difference was higher in LM than NM and this difference was 
significant only in suprabasal layer than in basal or connective tissue layer. This 
observation can be explained as stated by McCartan et al (1997)41 that when LM 
occurred in response to topical agents and contact allergens, the route of antigen would 
probably be across the epithelium in which case the number of activated LC might be 
expected to equal those found in LP41. 
Laine J et al (1999)37 reported that MHC class II expression by LC reflects a 
different route of antigen penetration (exogenic Vs endogenic). Reduced activity of LC 
has been shown in LM as compared to OLP. 
Dorrego MV et al (2002) 16 concluded that in LP the immunological reaction 
begin with LC activation, which presents the antigen to CD4 lymphocytes. These cells 
through ICAM 1 and VCAM 1 expression can activate CD8 lymphocyte leading to a 
chronic form of the disease. 
Sloberg et al (1984)58 considered that the increase in expression of LC in LP is a 
property of LC to improve their capacity to detect and present the antigen to the 
subepithelial T lymphocytes. The increased expression of Ia-like antigens on LC and the 
contemporary finding of Ia-like antigens on the subepithelial T-cells, support the opinion 
that the pathogenesis of OLP is mainly a cell-mediated type of immunological reaction. 
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In our study, mild CD1a expression was seen in the basal layer of 53.3 % LP as 
compared to LM, which was 60%, and in NM it was 80%. Intense staining was found 
only in 4% of LP. In the supra basal layer CD1a expression was mild in 26.7% and 
moderate in 46.7% of LP when compared with LM which was 66.7% and 2% 
respectively. The expression in NM was 40% in both mild and moderate intensities. 
However 6.7% intense staining was found only in LP. Though we observed a difference 
in the staining intensity pattern between the study groups, the difference was not 
significant. Similarly, CD1a expression in connective tissue of LP and LM shows 33.3% 
as mild & 46.7% as moderate staining while NM showing only 60% mild staining. 
However 20% intense staining was observed only in LP compared to LM & NM and this 
was statistically significant. 
Our observations, in which there is a significant increase in the expression of 
CD1a in different layers of epithelium and in connective tissue when compared to LM 
suggests the active role of LC in the pathogenesis of LP and the possible role of 
presentation of antigen to the T lymphocytes. 
Mega H et al (2001)43, Porter et al (1997)49 and Farthing PM et al (1990)20 
reported a significant increase in expression of LC in LP than in NM. There is a 
significant increase in HLA-DP, HLA-DQ and HLA-DR expression in LP possibly 
induced by local cytokines production.  
Laine J et al (1999)37 reported 19 cases of amalgam associated LM, in which 5 
cases had a higher expression of LC in the epithelium than in NM. They attributed this 
reaction to the trans-epithelial route of entrance of metal haptens released from dental 
restorative materials. The results obtained from various studies were consistent with our 
77 
  
present study. This suggests that in LP, LC is immunologically active and plays a role in 
lesion development.  
LP is an interface reaction consisting typically of T lymphocytes infiltration in the 
upper layer of connective tissue in close apposition to the basal layer of epithelium.41 
Both CD4 and CD8 T Cells are found in LP. The majority of the lymphocytes in the 
infiltrate are CD8 and CD45RO memory positive cell. The latter cell sub type is not 
normally found in healthy mucosa21. CD4 T cells, which express CD45RO antigen, are 
called memory cells and they proliferate in response to recall antigen. These cells show 
stronger helper function for the production of antibody. Naive T cell loses the CD45RA 
antigen after activation and begins to express CD45RO69. 
In our study memory T cells were identified by using CD45RO antibody. The 
present study demonstrated a higher expression of CD45RO in connective tissue layer of 
LP (53.3% intense staining) when compared to LM (20% intense staining) and no intense 
staining in NM. However NM showed 60% mild & 30% moderate staining. This 
difference was statistically significant. In LP, there are two populations of CD4 helper 
cell. One is CD45RA with suppressor inducer activity and the second is CD45RO, which 
serves as memory cell.  The latter group predominates in LP5. 
 Porter SR et al (1997) 49 reported that in LP majority of T lymphocytes express 
αβ TCR and are CD45RO +ve memory T cells. Walton LJ et al (1998) 66 reported that 
circulating memory CD45RO T cells were increased from 49.1% in controls to 65.5 % in 
LP.  
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Rudrigues Nunez et al (2001)52 reported the mean proportion of CD45RO 
lymphocyte with higher expression in atrophic erosive LP than in patients with reticular 
LP. Kirby C et al (1995)32 reported the presence of lymphocytes function associated 
antigen 3 (LFA-3) on LC. This may be an important aspect of disease development since 
in OLP, LC are highly activated. These cells also express VCAM-1 and ICAM-1 and 
present the antigen to memory T- cells (CD45RO), the predominant phenotype in LP.  
McCartan et al (1997)42 reported that although the T cell numbers are lower in 
LM than LP, the CD4/CD8 ratio is similar in these two conditions. Lymphocyte in LM 
was that of T helper lymphocyte with a suppressor/inducer phenotype 
CD45RA+ve/CD29-ve predominance in connective tissues infiltrate, while in LP the cell 
type is T helper/inducer cell expressing activation and proliferation antigen CD45RA -ve 
/ CD29 +ve / HLADP +ve41 . 
In LP lymphocytes are recruited into the mucosa by upregulation of adhesion 
molecule expression, possibly driven by cytokines. The damage to keratinocytes and the 
basement membrane is predominantly cytotoxic T lymphocytes mediated. Furthermore 
the activation of T lymphocytes and the resultant generation of cytokines are likely to 
perpetuate that LP is a cell-mediated immune response49. 
In LP the inflammatory infiltrate consists of significant number of CD4 T cells in 
the lamina propria and CD8 T cells in close proximity to epithelial basement membrane. 
Accumulation of CD8 cells seems to increase gradually in disease progression15. CD4 
helper T cells are stimulated to secrete Th1 cytokine IL2 & IFNγ. Subsequently CD8 
cytotoxic T cells may be activated by the combination of antigen associated with MHC 
Class I on basal keratinocyte and by CD4 T cell derived IL2 & IFN γ. Activated CD8 
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cytotoxic T cell trigger basal keratinocytes apoptosis in LP31. In our study also the 
CD45RO staining intensity in LP was higher than in LM & NM.  These results were 
consistent with the previous studies cited above.  
LP is triggered by some events that cause CD4/CD45RA +ve lymphocytes to 
differentiate into CD4/CD29+ve lymphocytes. From this point, immunosuppressive 
mechanisms are reduced, leading to an accumulation of memory CD45RO T cell52. 
The results of the present study demonstrate that there is a significant increase in 
the number and expression of LC and expression of memory T helper cell in LP than in 
LM. This clearly indicates that the route of antigen presentation and penetration is 
different between these two lesions.  However in LM due to topical agents or contact 
allergens, it is possible that the route of antigen presentation could be trans-epithelial, 
which is different from the LM associated with systemic drug administration. 
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Summary & Conclusion 
 
 
  
 
 
• A total of 40 patients were included in our study, comprising of 15 patients of LP, 
15 LM and 10 NM. 
• In our study, the mean age of LP was 36(± 17) years for males and 44(± 12) years 
for females, whereas LM was 38(± 17) years for males and 40(± 11) years for 
females. Both LP & LM showed a female predominance. 
• Buccal mucosa was the affected site in all cases of LP, however 60% cases of LM 
also showed the same site of occurrence. 80% LP showed bilateral distribution 
whereas 93% of LM had unilateral distribution. 
• Immunohistochemical study was done to evaluate the number and expression of 
LC, and to demonstrate the expression of T cells in LP, LM & NM. 
• Increased number of LC was observed in LP, in the basal and supra basal layer of 
epithelium and in the connective tissue compared to LM and NM by using CD1a 
staining. 
• Increased intensity of expression of LC was observed in LP, in basal and supra 
basal layer of epithelium compared to LM, NM and this was not statistically 
significant. 
• Increased CD1a expression was observed in the connective tissue in the sequence 
of LP> LM > NM and this was statistically significant. 
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• Increased CD45RO expression was observed in the connective tissue in the 
sequence of LP> LM > NM and this difference in staining intensity was 
statistically significant. 
• The present study clearly demonstrates a statistically significant increase in 
number and expression of LC and also an increase in the expression of memory T 
cell in LP than in LM, indicating the possible different immunopathogenic 
mechanisms. 
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Annexure 
  
LICHENOID MUCOSITIS INDUCING DURGS23 
• Antimalarials 
Quinacrine and Chloroquine 
Quinine and Quinidine 
• Antihypertensive agents 
β-adrenergic blocking agents 
Angiotensin-converting enzyme inhibitos 
Methyl dopa 
• Diuretics 
Thiazide diuretics 
Furosemide 
Spironolactone 
• Sulfonyl urea hypoglycemic agents 
• Non-steroidal anti-inflammatory drugs 
• Gold salts 
• Pencillamine 
• Tetracycline 
• Allopurinol 
• Ketaconozole 
• Heavy metals 
Mercurials 
Arsenicals 
Bismuth 
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